MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.braindev.2013.11.009

Медицинская библиотека · Brain & development · 2013

Intragenic mutations in SMN1 may contribute more significantly to clinical severity than SMN2 copy numbers in some spinal muscular atrophy (SMA) patients.

Yamamoto Tomoto, Sato Hideyuki, Lai Poh San, Nurputra Dian Kesumapramudya, Harahap Nur Imma Fatimah, Morikawa Satoru, Nishimura Noriyuki, Kurashige Takashi, Ohshita Tomohiko, Nakajima Hideki, Yamada Hiroyuki, Nishida Yoshinobu, Toda Soichiro, Takanashi Jun-Ichi, Takeuchi Atsuko, Tohyama Yumi, Kubo Yuji, Saito Kayoko, Takeshima Yasuhiro, Matsuo Masafumi, Nishio Hisahide

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused by deletion or intragenic mutation of SMN1. SMA is classified into several subtypes based on clinical severity. It has been reported that the copy number of SMN2, a highly homologous gene to SMN1, is associated with clinical severity among SMA patients with homozygous deletion of SMN1. The purpose of this study was to clarify the genotype-phenotype relationship among the patients without homozygous deletion of SMN1.

METHODS

We performed molecular genetic analyses of SMN1 and SMN2 in 112 Japanese patients diagnosed as having SMA based on the clinical findings. For the patients retaining SMN1, the PCR or RT-PCR products of SMN1 were sequenced to identify the mutation.

RESULTS

Out of the 112 patients, 106 patients were homozygous for deletion of SMN1, and six patients were compound heterozygous for deletion of one SMN1 allele and intragenic mutation in the retained SMN1 allele. Four intragenic mutations were identified in the six patients: p.Ala2Val, p.Trp92Ser, p.Thr274TyrfsX32 and p.Tyr277Cys. To the best of our knowledge, all mutations except p.Trp92Ser were novel mutations which had never been previously reported. According to our observation, clinical severity of the six patients was determined by the type and location of the mutation rather than SMN2 copy number.

CONCLUSION

SMN2 copy number is not always associated with clinical severity of SMA patients, especially SMA patients retaining one SMN1 allele.

Для цитирования: Yamamoto Tomoto, Sato Hideyuki, Lai Poh San, Nurputra Dian Kesumapramudya, Harahap Nur Imma Fatimah, Morikawa Satoru, Nishimura Noriyuki, Kurashige Takashi, Ohshita Tomohiko, Nakajima Hideki, Yamada Hiroyuki, Nishida Yoshinobu, Toda Soichiro, Takanashi Jun-Ichi, Takeuchi Atsuko, Tohyama Yumi, Kubo Yuji, Saito Kayoko, Takeshima Yasuhiro, Matsuo Masafumi, Nishio Hisahide. Intragenic mutations in SMN1 may contribute more significantly to clinical severity than SMN2 copy numbers in some spinal muscular atrophy (SMA) patients.. Brain & development. 2013. DOI: 10.1016/j.braindev.2013.11.009.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.